ACE and diabetes mellitus: Such an understanding may suggest the development of personalized treatments based on ACE and AGTR1 genetic polymorphisms to lower elevated TG levels in elderly diabetic female patients that have the potential to normalize the dyslipidaemia induced by diabetes mellitus.